Ischaemia modified albumin in the diagnosis of acute coronary syndromes

Resuscitation

Volumn 80, Issue 3, 2009, Pages 306-310

  Pantazopoulos, Ioannis ^a   Papadimitriou, Lila ^a   Dontas, Ismene ^a   Demestiha, Theano ^a   Iakovidou, Nikoleta ^a   Xanthos, Theodoros ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Acute coronary syndromes; Albumin cobalt binding test; Ischaemia modified albumin

Indexed keywords

CREATINE KINASE MB; ISCHEMIA MODIFIED ALBUMIN; MYOGLOBIN; TROPONIN I;

ACUTE CORONARY SYNDROME; CREATINE KINASE BLOOD LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE MARKER; EARLY DIAGNOSIS; ELECTROCARDIOGRAM; HEART MUSCLE ISCHEMIA; HEART MUSCLE NECROSIS; HUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REVIEW;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; DIAGNOSIS, DIFFERENTIAL; HUMANS; MYOCARDIAL ISCHEMIA; SERUM ALBUMIN;

EID: 59649087990     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2008.10.035     Document Type: Review

References (49)

1. Duseja R., and Feldman J.A. Missed acute cardiac ischemia in the ED: limitations of diagnostic testing. Am J Emerg Med 22 (2004) 219-225
2. Roy D., Quiles J., Aldama G., et al. Ischemia modified albumin for the assessment of patients presenting to the emergency department with acute chest pain but normal or non-diagnostic 12-lead electrocardiograms and negative cardiac troponin T. Int J Cardiol 97 (2004) 297-301
3. Peacock F., Morris D.L., Anwaruddin S., et al. Meta-analysis of ischemia-modified albumin to rule out acute coronary syndromes in the emergency department. Am Heart J 152 (2006) 253-262
4. Pope J.H., Aufderheide T.P., Ruthazer R., et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med 342 (2000) 1163-1170
5. Montagnana M., Lippi G., and Guidi G.C. New perspectives in the diagnostic approach to acute coronary syndrome. Recenti Prog Med 96 (2005) 171-177
6. Rajappa M., and Sharma A. Biomarkers of cardiac injury: an update. Angiology 56 (2005) 677-691
7. Green G.B. Green SF markers of myocardial injury in the evaluation of the emergency department patient with chest pain. In: Wu A.H.B. (Ed). Cardiac markers (1998), Humana Press, Totawa, NJ 75-89
8. Ryan T.J., Anderson J.L., Antman E.M., et al. ACC/AHA guidelines for the management of patients with acute myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Acute Myocardial Infarction). J Am Coll Cardiol 28 (1996) 1328-1428
9. Christenson R.H., and Azzazy H.M.E. Biochemical markers of the acute coronary syndromes. Clin Chem 44 (1998) 1855-1864
10. Lippi G., Montagnana M., Salvagno G.L., and Guidi G.C. Potential value for new diagnostic markers in the early recognition of acute coronary syndromes. CJEM 8 (2006) 27-31
11. Karras D.J., and Kane D.L. Serum markers in the emergency department diagnosis of acute myocardial infarction. Emerg Med Clin North Am 19 (2001) 321-337
12. Morrow D.A., de Lemos J.A., Sabatine M.S., and Antman E.M. The search for a biomarker of cardiac ischemia. Clin Chem 49 (2003) 537-539
13. Lippi G., Montagnana M., and Guidi G.C. Albumin cobalt binding and ischemia modified albumin generation: an endogenous response to ischemia?. Int J Cardiol 108 (2006) 410-411
14. Anwaruddin S., Januzzi Jr. J.L., Baggish A.L., Lewandrowski E.L., and Lewandrowski K.B. Ischemia modified albumin improves the usefulness of standard cardiac biomarkers for the diagnosis of myocardial ischemia in the emergency department setting. Am J Clin Pathol 123 (2005) 140-145
15. Worster A., Devereaux P.J., Heels-Ansdell D., et al. Capability of ischemia modified albumin to predict serious cardiac outcomes in the short term among patients with potential acute coronary syndrome. CMAJ 172 (2005) 1685-1690
16. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M.J., Samimi-Fard S., Reiter R.J., and Kaski J.C. Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction. Atherosclerosis 199 (2008) 73-78
17. Kumar A., Sivakanesan R., and Gunasekera S. Ischemia modified albumin: a potent marker in acute myocardial infarction in normolipidaemic. Pak J Med Sci 24 (2008) 364-367
18. Carreiro-Lewandowski E. Update on cardiac biomarkers. Lab Med 37 (2006) 598-605
19. Apple F.S., Wu A.H., Mair J., et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 51 (2005) 810-824
20. Bush H.S., Ferguson III J.J., Angelini P., and Willerson J.T. Twelve-lead electrocardiographic evaluation of ischemia during percutaneous transluminal coronary angioplasty and its correlation with acute reocclusion. Am Heart J 121 (1991) 1591-1599
21. Dellborg M., Emanuelsson H., and Swedberg K. Silent myocardial ischemia during coronary angioplasty. Cardiology 82 (1993) 325-334
22. Bertinchant J.P., Polge A., Ledermann B., et al. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris. Am J Cardiol 84 (1999) 51-57
23. Bar-or D., Winkler J.V., Vanbenthuysen K., Harris L., Lau E., and Hetzel F.W. Reduced albumin-cobalt binding with transient myocardial ischemia after elective percutaneous transluminal coronary angioplasty: a preliminary comparison to creatine kinase-MB, myoglobin, and troponin I. Am Heart J 141 (2001) 985-991
24. Quiles J., Roy D., Gaze D., et al. Relation of ischemia-modified albumin (IMA) levels following elective angioplasty for stable angina pectoris to duration of balloon-induced myocardial ischemia. Am J Cardiol 92 (2003) 322-324
25. Garrido I.P., Roy D., Calvino R., et al. Comparison of ischemia modified albumin levels in patients undergoing percutaneous coronary intervention for unstable angina pectoris with versus without coronary collaterals. Am J Cardiol 93 (2004) 88-90
26. Cho D.K., Choi J.O., Kim S.H., et al. Ischemia-modified albumin is a highly sensitive serum marker of transient myocardial ischemia induced by coronary vasospasm. Coron Artery Dis 18 (2007) 83-87
27. Sinha M.K., Roy D., Gaze D.C., Collinson P.O., and Kaski J.C. Role of "Ischemia Modified Albumin", a new biochemical marker of myocardial ischaemia, in the early diagnosis of acute coronary syndromes. Emerg Med J 21 (2004) 29-34
28. Bhagavan N.V., Lai E.M., Rios P.A., et al. Evaluation of human serum albumin cobalt binding assay for the assessment of myocardial ischemia and myocardial infarction. Clin Chem 49 (2003) 581-585
29. Lee Y.W., Kim H.J., Cho Y.H., Shin H.B., Choi T.Y., and Lee Y.K. Application of albumin-adjusted ischemia modified albumin index as an early screening marker for acute coronary syndrome. Clin Chim Acta 384 (2007) 24-27
30. Christenson R.H., Duh S.H., Sanhai W.R., et al. Characteristics of an Albumin Cobalt Binding Test for assessment of acute coronary syndrome patients: a multicenter study. Clin Chem 47 (2001) 464-470
31. Rao A.C., Naeem N., John C., Collinson P.O., Canepa-Anson R., and Joseph S.P. Direct current cardioversion does not cause cardiac damage: evidence from cardiac troponin T estimation. Heart 80 (1998) 229-230
32. Roy D., Quiles J., Sinha M., Aldama G., Gaze D., and Kaski J.C. Effect of direct-current cardioversion on ischemia-modified albumin levels in patients with atrial fibrillation. Am J Cardiol 93 (2004) 366-368
33. Dworschak M., Franz M., Khazen C., Czerny M., Haisjackl M., and Hiesmayr M. Mechanical trauma as the major cause of troponin T release after transvenous implantation of cardioverter/defibrillators. Cardiology 95 (2001) 212-214
34. Nikolaou N., Spanodimos S., Tsaglis E., et al. Biochemical evidence of cardiac damage following transvenous implantation of a permanent antibradycardia pacemaker lead. Pacing Clin Electrophysiol 28 (2005) 1174-1181
35. Sbarouni E., Georgiadou P., Panagiotakos D., Livanis E., Theodorakis G.N., and Kremastinos D.T. The ischemia modified albumin in relation to pacemaker and defibrillator implantation. Pacing Clin Electrophysiol 31 (2008) 83-87
36. Chawla R., Navendu G., Rajneesh C., and Shweta G. Ischemia modified albumin: a novel marker for acute coronary syndrome. Ind J Clin Biochem 21 (2006) 77-82
37. Dominguez-Rodriguez A., Abreu-Gonzalez P., Garcia-Gonzalez M.J., Samimi-Fard S., and Kaski J.C. Relation of ischemia-modified albumin levels and left ventricular systolic function in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Clin Chim Acta 388 (2008) 196-199
38. Aparci M., Kardesoglu E., Ozmen N., et al. Prognostic significance of ischemia-modified albumin in patients with acute coronary syndrome. Coron Artery Dis 18 (2007) 367-373
39. Turedi S., Gunduz A., Mentese A., et al. Value of ischemia modified albumin in the diagnosis of pulmonary embolism. Am J Emerg Med 25 (2007) 770-773
40. Gunduz A., Turedi S., Mentese A., et al. Ischemia-modified albumin in the diagnosis of acute mesenteric ischemia: a preliminary study. Am J Emerg Med 26 (2008) 202-205
41. Abboud H., Labreuche J., Meseguer E., et al. Ischemia-modified albumin in acute stroke. Cerebrovasc Dis 23 (2007) 216-220
42. Roy D., Quiles J., Sharma R., et al. Ischemia-modified albumin concentrations in patients with peripheral vascular disease and exercise-induced skeletal muscle ischemia. Clin Chem 50 (2004) 1656-1660
43. Zapico-Muniz E., Santalo-Bel M., Merce-Muntanola J., Montiel J.A., Martinez-Rubio A., and Ordonez-Llanos J. Ischemia-modified albumin during skeletal muscle ischemia. Clin Chem 50 (2004) 1063-1065
44. Apple F.S., Quist H.E., Otto A.P., Mathews W.E., and Murakami M.M. Release characteristics of cardiac biomarkers and ischemia-modified albumin as measured by the albumin cobalt-binding test after a marathon race. Clin Chem 48 (2002) 1097-1100
45. Sbarouni E., Georgiadou P., Theodorakis G.N., and Kremastinos D.T. Ischemia modified albumin in relation to exercise stress testing. J Am Coll Cardiol 48 (2006) 2482-2484
46. Lippi G., Montagnana M., Salvagno G.L., and Guidi G.C. Standardization of ischemia-modified albumin testing: adjustment for serum albumin. Clin Chem Lab Med 45 (2007) 261-262
47. Lebrun E., Maitre B., Grenier-Sennelier C., et al. Effect of D-dimer testing on the diagnostic strategy of suspected pulmonary embolism: an observational study of practice patterns and costs. Eur Radiol 10 (2000) 433-434
48. Kabrhel C., Matts C., Mc Namara M., Katz J., and Ptak T. A highly sensitive ELISA D-dimer increases testing but not diagnosis of pulmonary embolism. Acad Emerg Med 13 (2006) 519-524
49. Goldstein N.M., Kollef M.H., Ward S., and Gage B.F. The impact of the introduction of a rapid D-dimer assay on the diagnostic evaluation of suspected pulmonary embolism. Arch Intern Med 161 (2001) 567-571